U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C5H4O2
Molecular Weight 96.0841
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 4-CYCLOPENTENE-1,3-DIONE

SMILES

O=C1CC(=O)C=C1

InChI

InChIKey=MCFZBCCYOPSZLG-UHFFFAOYSA-N
InChI=1S/C5H4O2/c6-4-1-2-5(7)3-4/h1-2H,3H2

HIDE SMILES / InChI

Approval Year

PubMed

PubMed

TitleDatePubMed
Prostaglandin J2 metabolites inhibit aromatase activity by redox-sensitive mechanisms: potential implications for breast cancer therapy.
2003 Feb 20
Thermal decomposition of specifically phosphorylated D-glucoses and their role in the control of the Maillard reaction.
2003 May 21
Design of hypoxia-targeting protein tyrosine kinase inhibitor using an innovative pharmacophore 2-methylene-4-cyclopentene-1,3-dione.
2004 Mar 11
Experimental study on the thermal oxidation of 2-chlorophenol in air over the temperature range 450-900 degrees C.
2006 Mar
Cavity ringdown spectrum of the T(1)(n,pi*) <-- S(0) transition of 4-cyclopentene-1,3-dione.
2009 Nov 26
Name Type Language
4-CYCLOPENTENE-1,3-DIONE
Systematic Name English
NSC-155336
Code English
Code System Code Type Description
NSC
155336
Created by admin on Fri Dec 15 18:07:07 GMT 2023 , Edited by admin on Fri Dec 15 18:07:07 GMT 2023
PRIMARY
CAS
930-60-9
Created by admin on Fri Dec 15 18:07:07 GMT 2023 , Edited by admin on Fri Dec 15 18:07:07 GMT 2023
PRIMARY
PUBCHEM
70258
Created by admin on Fri Dec 15 18:07:07 GMT 2023 , Edited by admin on Fri Dec 15 18:07:07 GMT 2023
PRIMARY
EPA CompTox
DTXSID80239235
Created by admin on Fri Dec 15 18:07:07 GMT 2023 , Edited by admin on Fri Dec 15 18:07:07 GMT 2023
PRIMARY
FDA UNII
P054EQ880I
Created by admin on Fri Dec 15 18:07:07 GMT 2023 , Edited by admin on Fri Dec 15 18:07:07 GMT 2023
PRIMARY
MESH
C017848
Created by admin on Fri Dec 15 18:07:07 GMT 2023 , Edited by admin on Fri Dec 15 18:07:07 GMT 2023
PRIMARY
ECHA (EC/EINECS)
213-219-3
Created by admin on Fri Dec 15 18:07:07 GMT 2023 , Edited by admin on Fri Dec 15 18:07:07 GMT 2023
PRIMARY